C1519254||S116R Phosphorylation Site
C0026882||Mutation
C0086418||Human
C0079349||Fibroblast Growth Factor-1
C1752930||Mitogenic
C0860801||Glucose-Lowering Activities
C0079349||Fibroblast growth factor-1
C0079349||Fibroblast growth factor-1
C0086418||human
C0018284||mitogen
C0021641||insulin
C0037080||signals
C0206364||tyrosine kinase receptor
C0525010||autocrine
C0521447||nuclear
C1154545||intracrine pathway
C0031715||Phosphorylation
C0079349||Fibroblast growth factor-1
C0036720||serine 116
C0036720||serine 116
C3158094||regulate
C1154545||intracrine signaling
C0036720||serine 116
C1707271||amino acid C-terminal loop
C0574031||functional determinants
C0019134||heparin
C0019143||heparan sulfate
C0038734||thiol
C0525021||nuclear localization
C0521447||nuclear
C0023688||ligand
C0596957||structural dynamics
C0026882||Mutational
C0574031||functional determinants
C0036720||S116R
C0243095||non-phosphorylatable
C3667982||bovine
C0079349||Fibroblast growth factor-1
C0086418||human
C0016026||FGF family
C0026882||S116R mutation
C0086418||human
C0079349||Fibroblast growth factor-1
C0026383||structural
C0026882||mutation
C0031715||phosphorylation
C0036720||S116R
C1257739||NIH 3T3
C0016030||fibroblast
C1752930||mitogenic stimulation
C0170936||fibroblast growth factor receptor-1c
C1514758||activation
C0860801||glucose lowering
C0028754||ob/ob
C0020456||hyperglycemic
C0025929||mice
C0079349||Fibroblast growth factor-1
C0170936||fibroblast growth factor receptor-1c
C0243095||non-phosphorylatable
C1154545||intracrine signaling